CXCR4 and lymphoma: Overactivated CXCR4 signaling synergistically induces a unique oncogenic transcriptional program in B cells through the PLK1/FOXM1 pathway mediated by TCL1, suggesting that abnormal CXCR4 activity is associated with pathogenesis, disease progression, and resistance to chemotherapy in malignant lymphoma.